Biomaterials Could Extend the Success of Immunotherapies
A New Review Paper Encourages Clinicians to Pull Ideas from the Desks of Engineers
Unlucky 13: Top Clinical Trial Failures of 2017
In Missing Their Primary Endpoints, These Drugs Sparked Layoffs, Losses, and a CEO Resignation
Bioelectricity, New Peer Reviewed Journal Announced
An Outstanding and Influential Foundation for a Dynamic, Emerging Field
Kite Earns Patent for Method to Increase Efficacy of CAR-T
Company Snags Rights for Use of Optimal Preconditioning Regimen
Reprints And Permissions
Genetic Engineering & Biotechnology News (GEN) is pleased to announce our partnership with Copyright Clearance Center to meet your licensing needs.
With Copyright Clearance Center's Rightslink® service it's faster and easier than ever before to secure permission from GEN to reuse our content in a book, journal/magazine, newsletter/newspaper, CD-ROM/DVD, brochure/pamphlet, photocopy, coursepack, email, slide kit/presentation or order reprints.
Simply locate your desired content on http://www.genengnews.com/, click the Reprints link in the Keywords and Tools section to open Rightslink.
- Select the way you would like to reuse the content
- Create an account if you haven't already
- Accept the terms and conditions and you're done
For questions about using the Rightslink service, please contact Customer Support via phone 877/622-5543 (toll free) or 978/777-9929, or email firstname.lastname@example.org
If you prefer, please contact us directly:
Reprints & Permissions
Mary Ann Liebert, Inc., publishers
(914) 740-2100 or (800) M-LIEBERT